Gains on chromosome arm 9q represent a novel and independent marker of adverse prognosis in multiple myeloma patients receiving upfront high-dose chemotherapy and autologous stem cell transplantation.

被引：0
作者：
Liebisch, P
Benner, A
Tschajka, K
Wendl, C
Goldschmidt, H
Döhner, H
机构：
[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
[2] German Canc Res Ctr, Cent Unit Biostat, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Med Klin 5, Heidelberg, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：447A / 447A
页数：1
相关论文
共 50 条
[41]   The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma [J].
Lee, JL ;
Kim, SB ;
Lee, GW ;
Ryu, MH ;
Kim, E ;
Kim, S ;
Kim, WK ;
Lee, JS ;
Kim, SH ;
Suh, C .
YONSEI MEDICAL JOURNAL, 2003, 44 (05) :800-810
[42]   Health related quality of life of multiple myeloma patients treated with high dose chemotherapy and autologous peripheral blood stem cell transplantation. [J].
Gulbrandsen, N ;
Wisloff, F .
BLOOD, 1998, 92 (10) :728A-728A
[43]   Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation [J].
Frimpong, Justina Ofori ;
Tombleson, Rebecca ;
Alsina, Melissa ;
Shapiro, Jamie ;
Kim, Jongphil ;
Yue, Binglin ;
Perkins, Janelle ;
Nishihori, Taiga .
BLOOD, 2016, 128 (22)
[44]   Use of Netupitrant/palonosetron in Multiple Myeloma Patients Receiving High-dose Melphalan and Autologous Stem Cell Transplantation: A Single Centre Experience [J].
Loteta, Barbara ;
Naso, Virginia ;
Ferreri, Anna ;
Moscato, Tiziana ;
Console, Giuseppe ;
Irrera, Giuseppe ;
Provenzano, Fabio ;
Cusumano, Giuseppa ;
Russo, Letteria ;
Meliambro, Nicola ;
Romeo, Valentina ;
Porcino, Domenico ;
Gallo, Salvatore ;
Gangemi, Tiziana ;
Rossetti, Antonio Maria ;
Martino, Massimo .
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) :567-568
[45]   Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy [J].
Bo-Hee Lee ;
Seung Hwan Shin ;
Chang-Ki Min ;
Ho-Young Yhim ;
Jae-Yong Kwak ;
Jeong-A Kim .
International Journal of Hematology, 2013, 97 :634-639
[46]   Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy [J].
Lee, Bo-Hee ;
Shin, Seung Hwan ;
Min, Chang-Ki ;
Yhim, Ho-Young ;
Kwak, Jae-Yong ;
Kim, Jeong-A .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) :634-639
[47]   Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma [J].
Sato, Shuku ;
Tsunoda, Shun ;
Kawahigashi, Teiko ;
Kamata, Wataru ;
Tamai, Yotaro .
ANNALS OF HEMATOLOGY, 2023, 102 (05) :1185-1191
[48]   Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma [J].
Shuku Sato ;
Shun Tsunoda ;
Teiko Kawahigashi ;
Wataru Kamata ;
Yotaro Tamai .
Annals of Hematology, 2023, 102 :1185-1191
[49]   Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma [J].
Asher, S. ;
Shah, R. ;
Ings, S. ;
Horder, J. ;
Newrick, F. ;
Nesr, G. ;
Kesse Adu, R. ;
Streetly, M. ;
Trompeter, S. ;
Lee, L. ;
Wisniowski, B. ;
Mahmood, S. ;
Xu, K. ;
Papanikalaou, X. ;
McMillan, A. ;
Popat, R. ;
Yong, K. ;
Sive, J. ;
Kyriakou, C. ;
Rabin, N. .
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) :1224-1227
[50]   High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years [J].
Mehta, J. ;
Singhal, S. .
BONE MARROW TRANSPLANTATION, 2007, 40 (12) :1101-1114
12345